GSK3B and Alzheimer disease: These results suggest that preventing CRMP2 hyperphosphorylation by Cdk5 and GSK-3β, two kinases activated in AD [37,38,39,40], safeguards against the cognitive decline induced by Aβ25–35 oligomers [90].